Antiangiogenic agent (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Antiangiogenic agent (unspecified), covering 2025-02-27 to 2025-02-27. Get the full timeline:
Most recent: Clinical Trial Update: Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC [Phase 2]